Topline data were announced from a phase 3 trial evaluating ecopipam in pediatric and adult patients with Tourette syndrome.

Edgewise Therapeutics' stock soars on positive Becker Muscular Dystrophy trial results. Learn why EWTX is a promising buy with derisked programs.

Despite a global slowdown in EV sales, Cadillac is remaining bullish about its prospects in Australia. The iconic General ...

The market may be turbulent, but innovation never stops — and that’s exactly why InvestorPlace Senior Analyst Louis Navellier ...

The 383 stroker engine is an iconic small block used by gearheads to pump more power out of their cars. Here's why it's so ...

Maharashtra Budget Announcements, Deputy CM Ajit Pawar Budget Speech 2025 Live Updates: Will the Mahayuti government be able ...